Midecamycin A2 is a macrolide antibiotic that is derived from the fermentation of certain Streptomyces species. It is known for its antibacterial properties, particularly against Gram-positive bacteria and some Gram-negative organisms. The compound features a large lactone ring structure, which is characteristic of macrolides, and contains multiple hydroxyl and methoxy groups that contribute to its biological activity. Midecamycin A2 is often used in veterinary medicine and has applications in treating respiratory infections and other bacterial diseases in animals. Its mechanism of action involves inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the growth and reproduction of bacteria. The substance is typically administered orally or via injection, and its pharmacokinetics can vary based on the route of administration. As with many antibiotics, the potential for resistance development is a concern, necessitating careful use and adherence to prescribed dosages. Overall, Midecamycin A2 represents an important tool in the arsenal against bacterial infections, particularly in veterinary contexts.

MidecamaycinA2

36025-69-1: Midecamycin A2 is a macrolide antibiotic that is derived from the fermentation of certain Streptomyces species. It is known for its antibacterial properties, particularly against Gram-positive bacteria and some Gram-negative organisms. The compound features a large lactone ring structure, which is characteristic of macrolides, and contains multiple hydroxyl and methoxy groups that contribute to its biological activity. Midecamycin A2 is often used in veterinary medicine and has applications in treating respiratory infections and other bacterial diseases in animals. Its mechanism of action involves inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the growth and reproduction of bacteria. The substance is typically administered orally or via injection, and its pharmacokinetics can vary based on the route of administration. As with many antibiotics, the potential for resistance development is a concern, necessitating careful use and adherence to prescribed dosages. Overall, Midecamycin A2 represents an important tool in the arsenal against bacterial infections, particularly in veterinary contexts.

<p>Midecamycin A3 is a macrolide compound that exhibits strong activity against Gram-positive bacteria, while showing weak activity against Gram-negative bacteria, mycobacteria, and fungi.</p>

CAS 36025-69-1

MidecamaycinA2

Midecamycin A3

Ref: TM-TN10977